|
GOSS
|
Gossamer Bio, Inc.
|
US
|
NASDAQ
|
|
GSK
|
GlaxoSmithKline PLC
|
US
|
NYSE
|
|
HOTH
|
Hoth Therapeutics, Inc.
|
US
|
NASDAQ
|
|
ICU
|
SeaStar Medical Holding Corporation
|
US
|
NASDAQ
|
|
IMMX
|
Immix Biopharma, Inc.
|
US
|
NASDAQ
|
|
INCY
|
Incyte Corporation
|
US
|
NASDAQ
|
|
INFI
|
Infinity Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
KALA
|
Kala Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
KOD
|
Kodiak Sciences Inc
|
US
|
NASDAQ
|
|
KRYS
|
Krystal Biotech, Inc.
|
US
|
NASDAQ
|
|
MLTX
|
MoonLake Immunotherapeutics
|
US
|
NASDAQ
|
|
MTNB
|
Matinas Biopharma Holdings, Inc.
|
US
|
AMEX
|
|
NLTX
|
Neoleukin Therapeutics, Inc.
|
US
|
NASDAQ
|
|
NVO
|
Novo Nordisk A/S
|
US
|
NYSE
|
|
OCUL
|
Ocular Therapeutix, Inc.
|
US
|
NASDAQ
|
|
OCUP
|
Ocuphire Pharma, Inc.
|
US
|
NASDAQ
|
|
OLK
|
Olink Holding AB
|
US
|
NASDAQ
|
|
OMER
|
Omeros Corporation
|
US
|
NASDAQ
|
|
OPTN
|
OptiNose, Inc.
|
US
|
NASDAQ
|
|
PFE
|
Pfizer, Inc.
|
US
|
NYSE
|